Ailurus Bio
The biocomputer company, making biology a general-purpose technology
The biocomputer company, making biology a general-purpose technology
Ailurus Bio is a biocomputer company that aims to revolutionize biology by making it a general-purpose technology, as accessible as computers. The company is committed to accelerating biological research through the development of innovative methods, tools, and techniques, effectively programming biology into productivity tools. Founded in 2022, Ailurus Bio operates within the Biopharma, Biotechnology, and Life Sciences industries. The company recently secured funding in its latest investment round on 31 October 2022. The details of the investors involved in this round are yet to be disclosed. For further information, visit their website at ailurus.bio.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Funding Round | Unknown | - | 31 Oct 2022 |
No recent news or press coverage available for Ailurus Bio.
We care about your data, and we'd love to use cookies make your experience better.
